Hemavathi Baskarane
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH study.
Journal: Frontiers in pharmacology
Published: October 25, 2025
Randomized, double-blind, placebo-controlled study of oral duloxetine in prevention of acute pain syndrome in breast cancer patients receiving paclitaxel (DOPA study).
Journal: Trials
Published: September 03, 2025
Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North India.
Journal: JCO global oncology
Published: July 11, 2025
Primary de novo Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature.
Journal: International journal of surgical pathology
Published: April 28, 2025
Association of serum cyclooxygenase-2 levels with hand-foot syndrome in patients receiving capecitabine: an exploratory analysis of D-TORCH study.
Journal: Ecancermedicalscience
Published: February 19, 2025
Baseline retinoblastoma transcriptional corepressor 1 (Rb1) functional inactivation is a pre-requisite but not sufficient for small-cell histological transformation in epidermal growth factor receptor (EGFR) mutant lung adenocarcinomas post-tyrosine kinase inhibitor therapy.
Journal: Virchows Archiv : an international journal of pathology
Published: January 29, 2025
'Plasma first' approach for detecting epidermal growth factor receptor mutation in advanced non-small cell lung carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: March 23, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026